Bio-Pharmaceutical Enterprise

Directory:

(1) Pfizer Pfizer

(2) GlaxoSmithKline (GSK)

(3) Novo Nordisk Nord and Novo Nordisk

(4) Kaiser Permanente
(5) Genentech

(6) Memorial Sloan Kettering Caner Center

(7) Harvard Medical School Harvard Medical School

(8) (Brigham and women ' s HOSPITAL,BWH) Brigham and Women's Hospital

(9) Arrowhead Corporation

(1) Pfizer Pfizer
USA, pharmaceuticals, antibiotics and vaccines

(2) GlaxoSmithKline (GSK)
Founding Company: GlaxoSmithKline, GSK, and GlaxoSmithKline, Inc. inanti-infection, central nervous system, respiration and gastrointestinal/metabolicThe four major medical fields represent the highest level in the world today and ranks the industry in the field of vaccines and antitumor drugs. In addition, the company is also a world leader in consumer health, including over-the-counter drugs, oral care products and nutritional health drinks. In October 2014, British pharmaceutical company GlaxoSmithKline Scrap said that all data on the safety and efficacy of Ebola vaccines could not be reached until the end of 2015, meaning that 2015 years to complete the Ebola vaccine study, the fastest vaccine in 2016. Study Hepatitis B vaccine.


(3) Novo Nordisk Nord and Novo Nordisk
Denmark, the world's leading biopharmaceutical company, is the world leader in insulin development and production for diabetes treatment.

(4) Kaiser Permanente
United States, nonprofit medical services organization

(5) Genentech
The American genetic engineering company, or Gene Tektronix, is a biotech company founded by venture capitalist Robert A.swanson and bio-chemist Dr. Herbertboyer in 1976, and is considered the initiator of the biotech industry. Founder Dr. Boyer, a pioneer in DNA recombination technology


(6) Memorial Sloan Kettering Caner Center

established in year, In the Upper West Side of Manhattan, formerly the New York Cancer Hospital, the oldest and largest private cancer center in the world, with The year-long history.

(7) Harvard Medical School Harvard Medical School
The University Faculty of Medical Harvard Medical School (DMS) in the Department of Science has offered four doctoral degrees in biomedical sciences (including chemistry and faculty from the Department of Biomolecular Pharmacology, cell biology, developmental and regenerative biology, genetics, and Biotechnology), in a multidisciplinary project with Harvard Arts and Sciences: Microbiology and molecular genetics, pathology, and other teachers from other departments, hospitals and research institutes), three programs from medical schools and university teachers: immunology, neuroscience and virology.

(8) (Brigham and women ' s HOSPITAL,BWH) Brigham and Women's Hospital

A famous hospital in Mission Mountain, Boston, Massachusetts, with Massachusetts General Hospital located in the long Wood Medical district.

Brigham and Women's Hospital is one of the main teaching hospitals of Harvard Medical School which is adjacent to the campus. Brigham and Women's Hospital is also associated with the Dana-farber Cancer Institute.

The Brigham and Women's Hospital was merged in 1975 by 3 Harvard-related Boston hospitals: Peter Bent Blagen Hospital (established in 1913), Robert Breck Blagen Hospital (1914) and Boston Women's Hospital, The latter itself is also a combination of the Boston Maternity Hospital (1832) and the Women's Free Hospital (1875).

(9) Arrowhead the Corporation

Focus on chronic hepatitis B

Arrowhead the Corporation is a clinical stage, targeted therapeutics company developing innovative treatments for obesity, chronic hepat ITIS B Infection

(10) Guizhou bailing Group Pharmaceutical Co., Ltd.

Finte by Guizhou Bailing Group Pharmaceutical Co., Ltd. is responsible for the new drug Declaration and industrial Development. The next step, will be the first affiliated Hospital of Suzhou University and Beijing Bionovo Pharmaceutical Technology Development Co., Ltd. began the Ⅰ phase clinical research . On-site experts interviewed by reporters said that clinical research will be divided into several stages, from the new drug listing will still take a long time.

Public information shows that only clear the nucleus of the Cccdna in order to completely eliminate the hepatitis B virus carrying state, which is the goal of anti-HBV treatment

(11) Beijing Bionovo Pharmaceutical Technology Development Co., Ltd.Business scope:Study on the Phase I of pharmaceutical technology for UPM

Bionovo is committed to becoming an investment risk avoidance platform for China's pharmaceutical industry by providing research and development institutions of pharmaceutical enterprises with project management clinical research and registered drug re-evaluation academic promotion outsourcing new drug investment and financing management and other professional and technical services to help partners accurately predict and effectively reduce the risk of new pharmaceutical products investment and marketing investment risks to assist developers to solve funds, etc. Research and development of bottleneck incubation projects to bring them to market early Founded in 2003, the existing staff of hundreds, who has a master's degree or above, has more than 20 people and dozens of other well-known experts and scholars in various fields as long-term consultant company under the Department of Medical Registration Risk assessment department of International Affairs Department of Marketing Customer service Department of the Department of Quality Control Audit Department of data management and Statistics Center personnel Administration Department and has 10

(12) Suzhou University Affiliated First hospital

National Hospital infection Monitoring network of the Ministry of Health

Jiangsu Province Health Department directly under the level three Grade A hospital, the southern Jiangsu Medical Guidance Center. It was formerly the "Bo Xi Hospital" founded by the American Christian Supervision Association in 1883 (nine years). October 1954, Yi name is Suzhou first People's Hospital. In September 1957 and September 1959, it was renamed as Affiliated Hospital of Suzhou Medical College and first affiliated Hospital of Suzhou Medical College. In April 2000, Suzhou Medical College and Suzhou University merged and renamed the first affiliated Hospital of Soochow University.

(13) Shanghai Pasteur Institute

A new breakthrough was made in the study of chronic hepatitis B therapeutic vaccines. Related papers are published online in the Journal of Virology.

In the process of hepatitis B chronic infection, the virus-specific effector cells are usually in a state of tolerance or exhaustion, active immunity can temporarily activate the effect T cells, but the specific immune and immune memory reaction quickly restored to the virus sustained infection formed immune tolerance state. Therefore, the researchers proposed a novel immune therapy concept based on the response of exogenous antigen T cells, and designed and constructed a recombinant HBV (RHBV) virus. RHBV activated exogenous T cell responses will eventually control the persistent infection of wild viruses.

Bio-Pharmaceutical Enterprise